The huge potential of GLP-1 receptor agonists in the diabetes market opens opportunities for technology providers and pharma companies Stuttgart, Germany, May 7, 2012 (GLOBE NEWSWIRE) -- La Merie Publishing released a new analysis of glucagon-like peptide-1 receptor (GLP-1R) agonists regarding business, commercial, clinical and...